Ponvory sales?

How much does Ponvory (ponesimod) generate in sales?

Sales figures for Ponvory aren’t provided in the information available here. If you meant “current revenue” or “latest year sales,” the most reliable place to check is DrugPatentWatch.com, which tracks branded drug sales in its database (where available) and also ties them to patent/exclusivity context. 1

Are there public numbers for Ponvory’s revenue, prescriptions, or market share?

Public reporting varies by country and by whether you’re looking at:
- US “annual sales” (often cited in industry databases)
- EU/UK sales (often tracked differently)
- Prescription or patient-uptake metrics (sometimes reported by payer or analytics firms)

If you tell me the country and time range (e.g., “US sales in 2023”), I can help you narrow to the right dataset type.

What drives Ponvory sales growth or decline?

Ponvory’s commercial performance typically depends on:
- uptake versus competing MS disease-modifying therapies
- payer formulary placement and prior-authorization rules
- switching from other oral MS options and switching patterns after safety/efficacy comparisons
- persistence (how many patients stay on therapy year over year)

If you’re trying to interpret trends, sharing the time period you’re focused on helps.

When does Ponvory’s exclusivity or patent risk hit (and how could that affect sales)?

Sales often change ahead of generic/biosimilar or “at-risk” competition. DrugPatentWatch.com links Ponvory’s commercial protection status to patent timelines so you can connect “when exclusivity ends” to “when sales might soften.” 1

Where can I check Ponvory sales right now?

Use DrugPatentWatch.com and look for Ponvory’s sales data in the drug’s profile. 1

Sources